Last reviewed · How we verify
NCT05386992: ABIP
Anthropometric and Biomechanical Analysis of the Infant Foot
NA trial testing Anthropometric study in Child, Only in 1,216 participants. Completed in 4 June 2023.
10 May 2023
Quick facts
| Lead sponsor | University of Las Palmas de Gran Canaria |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 1,216 |
| Start date | 30 July 2022 |
| Primary completion | 10 May 2023 |
| Estimated completion | 4 June 2023 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Anthropometric study
Conditions studied
- Child, Only — all drugs for Child, Only →
Sponsor
University of Las Palmas de Gran Canaria
Who can join
Adults 12 Months to 15, any sex, with Child, Only. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In the era of science and technology, footwear has become not only an essential item of clothing, but also another tool for the optimal development of children, the improvement of work and sports performance or the prevention and treatment of pathologies. The anthropometric characteristics of the child's foot differ considerably from those of the adult foot, in fact, it is not until the age of 18-19 years that the structure of the foot is finally consolidated. Therefore, it is essential that footwear manufacturers know these characteristics to achieve an adequate design. Current scientific evidence highlights the importance of considering the unique morphology of the infant foot, as well as the high functional demands to which footwear is subjected at these ages. There is a lack of studies that analyze in detail the shape of the child's foot.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Anthropometric Foot Variations in Children: A Cross-Sectional Study Supporting Sex-Based Last Design.
Domínguez MP, Blanco SG, Paralera-Morales C, Martínez AR, et al · · 2025 · cited 1× · PMID 40746028 · DOI 10.1002/jfa2.70069
Verify or expand the search:
- PubMed search for NCT05386992
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Child, Only
Currently open trials in the same condition.
- NCT07440771 — Effects of Traditional Game in School Going Children · NA · recruiting
- NCT07378995 — The Effect of Therapeutic Play Applied Before Intramuscular Injection · NA · recruiting
- NCT07379021 — Mindfulness-Based Emotion Regulation Training for Hospitalized Children · NA · recruiting
- NCT06426147 — L-citrulline to Improve Adverse Outcomes in Admitted Children (EChiLiBRiST, Clinical Trial 2, Inpatients) · NA · recruiting
- NCT07248501 — Effects of Bulgarian Exercises on Lower Limb Function in Children · NA · recruiting
Other University of Las Palmas de Gran Canaria trials
Trials by the same sponsor.
- NCT04962737 — Non-invasive Neuromodulation NESA Through Somatosensory Evoked Potentials and Sympathetic-cutaneous Responses · NA · not yet recruiting
- NCT06417450 — Usefulness of NESA Microcurrents in the Treatment of Children With Autism Spectrum Disorders · NA · completed
- NCT06134999 — Study of Patients With Knee Prostheses Treated With Noninvasive Neuromodulation · NA · completed
- NCT06138158 — Improvement of Fear-avoidance Beliefs in Patients With Chronic Low Back Pain · NA · completed
- NCT05800431 — NESA Microcurrents on Quality of Life in Geriatric Patients · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05386992 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Las Palmas de Gran Canaria
- Last refreshed: 6 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05386992.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing